2024 Q1 Form 10-Q Financial Statement

#000143774924003522 Filed on February 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $6.940M $6.144M $6.145M
YoY Change 17.31% -0.02% -27.99%
Cost Of Revenue $1.046M $911.0K $969.0K
YoY Change 12.47% -5.99% -48.38%
Gross Profit $5.894M $5.233M $5.176M
YoY Change 18.21% 1.1% -22.25%
Gross Profit Margin 84.93% 85.17% 84.23%
Selling, General & Admin $3.918M $3.739M $3.522M
YoY Change 17.38% 6.16% -7.73%
% of Gross Profit 66.47% 71.45% 68.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $57.00K $69.00K $49.00K
YoY Change 1.79% 40.82% -7.55%
% of Gross Profit 0.97% 1.32% 0.95%
Operating Expenses $5.021M $4.719M $4.540M
YoY Change 16.12% 3.94% 17.31%
Operating Profit $1.919M $1.425M $1.605M
YoY Change 20.54% -11.21% -42.41%
Interest Expense $568.0K $567.0K $563.0K
YoY Change 1.07% 0.71% -210.83%
% of Operating Profit 29.6% 39.79% 35.08%
Other Income/Expense, Net $467.0K
YoY Change 23250.0%
Pretax Income $2.122M $1.644M $1.509M
YoY Change 31.8% 8.95% -33.84%
Income Tax $582.0K $444.0K $390.0K
% Of Pretax Income 27.43% 27.01% 25.84%
Net Earnings $1.540M $1.200M $1.119M
YoY Change 28.87% 7.24% -41.51%
Net Earnings / Revenue 22.19% 19.53% 18.21%
Basic Earnings Per Share $0.20 $0.16 $0.15
Diluted Earnings Per Share $0.20 $0.16 $0.15
COMMON SHARES
Basic Shares Outstanding 7.675M 7.674M 7.574M
Diluted Shares Outstanding 7.700M 7.674M 7.581M

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $59.60M $59.62M $57.06M
YoY Change 2.98% 4.48% 4.67%
Cash & Equivalents $59.59M $59.61M $57.05M
Short-Term Investments $11.00K $11.00K $10.00K
Other Short-Term Assets $732.0K $603.0K $762.0K
YoY Change -16.82% -20.87% 35.35%
Inventory
Prepaid Expenses $732.0K $603.0K $762.0K
Receivables $2.556M $2.155M $2.075M
Other Receivables $273.0K $251.0K $257.0K
Total Short-Term Assets $63.43M $62.89M $60.15M
YoY Change 4.07% 4.55% 3.2%
LONG-TERM ASSETS
Property, Plant & Equipment $295.0K $282.0K $335.0K
YoY Change -10.06% -15.82% -72.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $182.0K $163.0K $157.0K
YoY Change 15.92% 3.82% -36.18%
Total Long-Term Assets $83.91M $82.12M $82.07M
YoY Change 2.29% 0.06% -0.07%
TOTAL ASSETS
Total Short-Term Assets $63.43M $62.89M $60.15M
Total Long-Term Assets $83.91M $82.12M $82.07M
Total Assets $147.3M $145.0M $142.2M
YoY Change 3.05% 1.96% 1.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $672.0K $745.0K $1.737M
YoY Change -68.77% -57.11% -38.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.169M $2.780M $2.685M
YoY Change 20.27% 3.54% -26.9%
LONG-TERM LIABILITIES
Long-Term Debt $39.32M $39.24M $38.94M
YoY Change 0.78% 0.76% 0.73%
Other Long-Term Liabilities $864.0K $186.0K
YoY Change 829.03% -66.43%
Total Long-Term Liabilities $40.18M $39.24M $39.13M
YoY Change 2.75% 0.28% -0.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.169M $2.780M $2.685M
Total Long-Term Liabilities $40.18M $39.24M $39.13M
Total Liabilities $58.41M $56.85M $55.56M
YoY Change 4.52% 2.31% -0.59%
SHAREHOLDERS EQUITY
Retained Earnings $66.58M $66.10M $65.43M
YoY Change 1.53% 1.03%
Common Stock $22.34M $22.06M $21.23M
YoY Change 3.86% 3.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $88.92M $88.16M $86.66M
YoY Change
Total Liabilities & Shareholders Equity $147.3M $145.0M $142.2M
YoY Change 3.05% 1.96% 1.29%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income $1.540M $1.200M $1.119M
YoY Change 28.87% 7.24% -41.51%
Depreciation, Depletion And Amortization $57.00K $69.00K $49.00K
YoY Change 1.79% 40.82% -7.55%
Cash From Operating Activities $1.873M $416.0K -$32.00K
YoY Change -5.74% -1400.0% -102.76%
INVESTING ACTIVITIES
Capital Expenditures $860.0K $46.00K $64.00K
YoY Change 493.1% -28.13% -212.28%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$860.0K -$250.0K -$381.0K
YoY Change 493.1% -34.38% 568.42%
FINANCING ACTIVITIES
Cash Dividend Paid $1.038M $1.026M
YoY Change 1.17% 1.79%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -1.025M -$1.037M -1.024M
YoY Change 0.2% 1.27% -102.73%
NET CHANGE
Cash From Operating Activities 1.873M $416.0K -32.00K
Cash From Investing Activities -860.0K -$250.0K -381.0K
Cash From Financing Activities -1.025M -$1.037M -1.024M
Net Change In Cash -12.00K -$871.0K -1.437M
YoY Change -101.47% -39.39% -103.72%
FREE CASH FLOW
Cash From Operating Activities $1.873M $416.0K -$32.00K
Capital Expenditures $860.0K $46.00K $64.00K
Free Cash Flow $1.013M $370.0K -$96.00K
YoY Change -45.01% -485.42% -107.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2356000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2287000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
22500000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
22500000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7673869
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7673869
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7671099
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7671099
CY2023Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-11-13
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 dei Document Type
DocumentType
10-Q
CY2023Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q4 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q4 dei Entity File Number
EntityFileNumber
001-36423
CY2023Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
CY2023Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
68-0176227
CY2023Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
7250 Redwood Boulevard, Suite 200
CY2023Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Novato
CY2023Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94945
CY2023Q4 dei City Area Code
CityAreaCode
415
CY2023Q4 dei Local Phone Number
LocalPhoneNumber
899-1555
CY2023Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7675363
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59605000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60476000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11000 usd
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
10000 usd
CY2023Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
2155000 usd
CY2023Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
2046000 usd
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
264000 usd
CY2023Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
253000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
603000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
669000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
251000 usd
CY2023Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
247000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
62889000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
63701000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
305000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
206000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
295000 usd
CY2023Q4 us-gaap Indefinite Lived Contractual Rights
IndefiniteLivedContractualRights
81466000 usd
CY2023Q3 us-gaap Indefinite Lived Contractual Rights
IndefiniteLivedContractualRights
81262000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
163000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
156000 usd
CY2023Q4 us-gaap Assets
Assets
145006000 usd
CY2023Q3 us-gaap Assets
Assets
145719000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1616000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3165000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
186000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
279000 usd
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
978000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
748000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2780000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4192000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
39240000 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
39164000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
14825000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
14611000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
56845000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
57967000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
22064000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
21800000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
66097000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
65952000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
88161000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
87752000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145006000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145719000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6144000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6145000 usd
CY2023Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1866000 usd
CY2022Q4 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1858000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1724000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1569000 usd
CY2023Q4 hnna Distribution Expense
DistributionExpense
149000 usd
CY2022Q4 hnna Distribution Expense
DistributionExpense
95000 usd
CY2023Q4 us-gaap Subadvisory Fees For Mutual Funds
SubadvisoryFeesForMutualFunds
911000 usd
CY2022Q4 us-gaap Subadvisory Fees For Mutual Funds
SubadvisoryFeesForMutualFunds
969000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
69000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
49000 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
4719000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
4540000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1425000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1605000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
567000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
563000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
786000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
467000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1644000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1509000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
444000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
390000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1200000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1119000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7672191
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7572454
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7673688
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7581157
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.14
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
87752000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1200000 usd
CY2023Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1055000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
246000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
88161000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
86298000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1119000 usd
CY2022Q4 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1041000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
262000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
86655000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
1200000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
1119000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
69000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
49000 usd
CY2023Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1000 usd
CY2022Q4 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1000 usd
CY2023Q4 hnna Change In Right Of Use Asset And Operating Lease Liability
ChangeInRightOfUseAssetAndOperatingLeaseLiability
-4000 usd
CY2022Q4 hnna Change In Right Of Use Asset And Operating Lease Liability
ChangeInRightOfUseAssetAndOperatingLeaseLiability
-1000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
76000 usd
CY2022Q4 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
73000 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
214000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
262000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
246000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
262000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
109000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
24000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
11000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
78000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-66000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-169000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
4000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-0 usd
CY2023Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
7000 usd
CY2022Q4 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1549000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1989000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
230000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
128000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
416000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
64000 usd
CY2023Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
204000 usd
CY2022Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
317000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-250000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-381000 usd
CY2023Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
1038000 usd
CY2022Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
1026000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1037000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1024000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
-871000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations
-1437000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60476000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58487000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
59605000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57050000 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
491000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
491000 usd
CY2023Q4 us-gaap Stock Issued1
StockIssued1
17000 usd
CY2022Q4 us-gaap Stock Issued1
StockIssued1
15000 usd
CY2023Q4 hnna Management Contracts Purchased Textblock
ManagementContractsPurchasedTextblock
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"><tbody><tr style="vertical-align: top;"><td style="width: 36pt;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>(<em style="font: inherit;">2</em>)</b></p> </td><td style="width: auto;"> <p style="margin: 0pt; text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><b>Management Contracts Purchased</b></p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Throughout its history, the Company has completed 12 purchases of the assets related to the management of 32 investment funds, some of which were reorganized into already existing Hennessy Funds. In accordance with Financial Accounting Standards Board (“FASB”) guidance, the Company periodically reviews the carrying value of its management contracts asset to determine if any impairment has occurred. The fair value of the management contracts asset was estimated as of <em style="font: inherit;"> September </em><em style="font: inherit;">30,</em> <em style="font: inherit;">2023,</em> by applying the income approach and is based on management estimates and assumptions, including third‑party valuations that utilize appropriate valuation techniques. It was determined there was no impairment as of such date. As of <em style="font: inherit;"> December 31, 2023</em>, management performed a qualitative analysis and determined it was more likely than <em style="font: inherit;">not</em> that there continued to be no impairment.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Under Accounting Standards Codification <em style="font: inherit;">350</em> — Intangibles - Goodwill and Other, intangible assets that have indefinite useful lives are <em style="font: inherit;">not</em> amortized but are tested at least annually for impairment. The Company considered various factors, such as likelihood of continued renewal, whether there are foreseeable limits on net cash flows, and whether the Company is dependent on a limited number of investors, in determining the useful life of the management contracts. Based on analysis, the Company considers the management contract asset to be an intangible asset with an indefinite useful life and <em style="font: inherit;">no</em> impairment as of the end of the current period. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The Company completed its most recent asset purchase on <em style="font: inherit;"> November </em><em style="font: inherit;">10,</em> <em style="font: inherit;">2023,</em> when it purchased assets related to the management of the CCM Small/Mid-Cap Impact Value Fund. This asset purchase added approximately $12 million to the Company’s assets under management at the time of closing. The purchase was consummated in accordance with the terms and conditions of that certain Transaction Agreement, dated as of <em style="font: inherit;"> April 26, 2023, </em>between the Company and Community Capital Management, LLC (the “CCM Transaction Agreement”). Upon completion of the transaction, the assets of CCM Small/Mid-Cap Impact Value Fund were reorganized into the Hennessy Stance ESG ETF.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">As of <em style="font: inherit;"> December 31, 2023, </em>there was a <em style="font: inherit;">second</em> asset purchase pending under the CCM Transaction Agreement, which is for the purchase of assets related to the management of the CCM Core Impact Equity Fund. The purchase is subject to customary closing conditions, including the approval of the shareholders of the CCM Core Impact Equity Fund. At the Special Meeting of Shareholders of the CCM Core Impact Equity Fund on <em style="font: inherit;"> January 31, 2024, </em>shareholders approved the purchase of assets related to the management of the CCM Core Impact Equity Fund by the Company. See Note <em style="font: inherit;">13,</em> "Subsequent Events," for additional information.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">In the current period, the Company capitalized $0.2 million in legal costs related to the CCM Transaction Agreement. </p>
CY2023Q4 hnna Number Of Purchases Of Assets
NumberOfPurchasesOfAssets
12 pure
CY2023Q4 hnna Number Of Investment Funds
NumberOfInvestmentFunds
32 pure
CY2023 hnna Management Contracts Purchased Impairment
ManagementContractsPurchasedImpairment
0 usd
CY2023Q4 hnna Management Contracts Purchased Impairment
ManagementContractsPurchasedImpairment
0 usd
CY2023Q4 hnna Number Of Open End Mutual Funds
NumberOfOpenEndMutualFunds
16 pure
CY2023Q4 hnna Notice Period For Termination Of Agreement
NoticePeriodForTerminationOfAgreement
P60D
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59417000 usd
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59417000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59392000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
59392000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
206000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
186000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y7M6D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.009 pure
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
191000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
191000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
186000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
554000 usd
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2260000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
317000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
310000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
745000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
595000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1616000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3165000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.27 pure
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.258 pure
CY2023Q4 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
40000.00 usd
CY2022Q4 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
30000.00 usd
CY2023Q4 us-gaap Other Commitment
OtherCommitment
0 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7672191
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7572454
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1497
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8703
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7673688
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7581157
CY2023Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.1375

Files In Submission

Name View Source Status
0001437749-24-003522-index-headers.html Edgar Link pending
0001437749-24-003522-index.html Edgar Link pending
0001437749-24-003522.txt Edgar Link pending
0001437749-24-003522-xbrl.zip Edgar Link pending
ex_606544.htm Edgar Link pending
ex_606545.htm Edgar Link pending
ex_606546.htm Edgar Link pending
ex_606547.htm Edgar Link pending
ex_614043.htm Edgar Link pending
ex_614044.htm Edgar Link pending
ex_615742.htm Edgar Link pending
ex_615743.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hnna-20231231.xsd Edgar Link pending
hnna20231231_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hnna-20231231_cal.xml Edgar Link unprocessable
hnna-20231231_def.xml Edgar Link unprocessable
hnna-20231231_lab.xml Edgar Link unprocessable
hnna-20231231_pre.xml Edgar Link unprocessable
hnna20231231_10q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending